As of early 2026, California ended Medi-Cal coverage for GLP-1 medications prescribed solely for weight loss, citing unsustainable costs and long-term budget strain
Why Do Peptides Need It
La prdida de peso asistida con semaglutida puede reducir la carga del corazn y los vasos sanguneos, lo que posiblemente disminuya algunos riesgos cardiovasculares
doi: 10.1101/gad.334219.119 62 ZouYSongWZhouLMaoYHongW
Commonly reported observations include injection site reactions, mild gastrointestinal effects, and transient flushing
Originally developed by Eli Lilly, it is investigated for its effects on glucose dependent insulinotropic polypeptide and GLP-1 receptor signaling pathways, with research applications spanning insulin release modulation, gastric emptying, food intake regulation, and blood sugar control in preclinical models